J&J Targets $50 Billion in Oncology Revenue, Acquires Halda for $3 Billion in Cash

J&J Targets $50 Billion in Oncology Revenue, Acquires Halda for $3 Billion in Cash

J&J Targets $50 Billion in Oncology Revenue, Acquires Halda for $3 Billion in Cash